How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

866 results for

Acne Vulgaris Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Acne

nodulocystic acne , which can be permanently disfiguring. In addition to the physical lesions, acne can 2018 8. Guidelines of care for the management of acne vulgaris FROM THE ACADEMY Guidelinesofcareforthemanagementofacnevulgaris Work Group: Andrea L. Zaenglein, MD (Co-Chair), a Arun L. Pathy, MD (Co-Chair), b Bethanee J. Schlosser, MD, PhD, c Ali Alikhan, MD, d Hilary E. Baldwin, MD, e Diane S. Berson, MD, f,g Whitney P. Bowe, MD, e Emmy M. Graber, MD, h,i Julie C. Harper, MD, j Sewon Kang, MD, k Jonette (...) . These can be found via searching the site. Top results for acne 1. Acne vulgaris Acne vulgaris - NICE CKS Clinical Knowledge Summaries Share Acne vulgaris - Summary Acne vulgaris is a chronic skin condition in which blockage or inflammation of the hair follicles and accompanying sebaceous glands (known as pilosebaceous units) occurs. It principally affects the face, the back, and the chest, and usually first occurs around the age of puberty. Acne is most prevalent among adolescents and young adults

2018 Trip Latest and Greatest

102. Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation (Full text)

Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation Oral antibiotics have been used for the treatment of acne vulgaris for six decades. Among dermatologists, tetracyclines represent at least three-fourths of the oral antibiotics prescribed in clinical practice. Unlike other specialties, antibiotic use in dermatology is predominantly for the treatment of noninfectious disorders (...) , such as acne vulgaris and rosacea, which usually involves prolonged therapy over several weeks to months as compared to short courses used to treat cutaneous infections. At the present time, doxycycline and minocycline are the most commonly prescribed tetracyclines in dermatology, used primarily for treatment of acne vulgaris with a long overall favorable track record of effectiveness and safety. Although both are commonly used, doxycycline may be chosen by clinicians more readily as there is a lower risk

2015 The Journal of clinical and aesthetic dermatology PubMed

103. Acne - Guidelines for Prescribing Topical Treatment

Acne - Guidelines for Prescribing Topical Treatment Acne - Guidelines for Prescribing Topical Treatment - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Acne - Guidelines for Prescribing Topical Treatment Acne vulgaris (acne) is the formation of comedones, papules, pustules, nodules, and/or cysts as a result of obstruction and inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland (...) want to assess the severity of the patient’s acne: Mild: Some papules or pustules; no nodules or cysts Moderate: Many papules and pustules; few nodules, no cysts Severe: Numerous papules and pustules; many nodules or cysts Rule out the following conditions which have signs / symptoms that may resemble acne vulgaris: Comedones Pustules Papules Nodules Other Open Closed Vulgaris X X X X X Conglobata X XX XX Cysts, abscesses, sinus tracts Fulminans X XX XX Ulcerating cysts Contact pomade use XX X

2018 medSask

104. Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey, 2005-2014. (PubMed)

Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey, 2005-2014. Racial health disparities are widespread in the United States, but little is known about racial disparities in the management of dermatological conditions.Nationally representative data on the management of acne vulgaris were gathered from the National Ambulatory Medical Care Survey (NAMCS) for the years 2005-2014. Visits to any specialist were included. Rao-Scott chi-square tests (...) and multivariate adjusted logistic regressions were used to identify differences in patient demographics, visit characteristics and acne medications across races.Black patients are less likely than white patients to visit a dermatologist (adjusted odds ratio (aOR) 0.48, p = 0.001), receive any acne medication (aOR 0.64, p = 0.01), receive a combination acne medication (aOR 0.52, p = 0.007) or receive isotretinoin (aOR 0.46, p = 0.03). Adjusting for management by a dermatologist eliminated the association

2017 Journal of Dermatological Treatment

105. Evidence-based recommendations for the management of acne fulminans and its variants. (Full text)

Evidence-based recommendations for the management of acne fulminans and its variants. Acne fulminans (AF) is a severe variant of inflammatory acne. It typically manifests as an explosive worsening and ulceration of skin lesions, and can be associated with systemic symptoms. However, there is a paucity of evidence-based information and no clear guidelines concerning the classification and treatment of AF.To better define the spectrum of AF and its variants, devise optimal therapeutic approaches (...) , and identify areas of future research.A panel of physicians with expertise in severe acne vulgaris was convened after a comprehensive literature review of severe acne variants. Priority topics were reviewed and presented by each panelist at a 5-hour conference. Following review of the audiotape and scribed notes from the conference, surveys were utilized to address points of controversy and to clarify consensus recommendations.Appropriate clinical case presentations and consensus survey questions were

2017 Journal of American Academy of Dermatology PubMed

106. Acne vulgaris

to treatment, adverse effects and use of comedongenic make up or face creams should be considered before swapping to an alternative product or the next treatment step. Have I got the right topic? Have I got the right topic? From age 12 years onwards. This CKS topic covers the management of acne vulgaris. This CKS topic does not cover the management of acne secondary to drugs or an underlying condition. There is a separate CKS topic on . The target audience for this CKS topic is healthcare professionals (...) guidelines Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne [ ]. Management of acne: Canadian clinical practice guideline [ ], A consensus-based practical and daily guide for the treatment of acne patients [ ], European evidence-based (S3) guideline for the treatment of acne – update 2016 [ ], Guidelines of care for the management of acne vulgaris [ ], and Acne: acne vulgaris [ ], and expert opinion in review articles [ ; ; ]. Assessment How should I assess a person

2014 NICE Clinical Knowledge Summaries

107. Impact of the M22-IPL Acne Filter on Acne Vulgaris

Impact of the M22-IPL Acne Filter on Acne Vulgaris Impact of the M22-IPL Acne Filter on Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Impact of the M22-IPL Acne Filter on Acne Vulgaris (...) Summary: Up to 20 healthy subjects age 15-45 years old ,Skin Phototype I-V,Study will be conducted in 1 site. Primary objectives is to evaluate the efficacy of IPL acne filter treatment for improvement of acne vulgaris as assessed by lesion count. Condition or disease Intervention/treatment Phase Acne Device: M22-IPL Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 13 participants Intervention Model: Single Group

2014 Clinical Trials

108. Acne clinical guideline

Acne clinical guideline Guidelines of care for the management of acne vulgaris - Journal of the American Academy of Dermatology Email/Username: Password: Remember me Search JAAD & JAAD Case Reports Search Terms Search within Search Access provided by Volume 74, Issue 5, Pages 945–973.e33 Guidelines of care for the management of acne vulgaris Work Group:, x Andrea L. Zaenglein Affiliations Penn State Hershey Medical Center, Hershey, Pennsylvania , MD (Co-Chair) a , x Arun L. Pathy Affiliations (...) translations or adaptations of the article | Fig 1 Treatment algorithm for the management of acne vulgaris in adolescents and young adults. The double asterisks (∗∗) indicate that the drug may be prescribed as a fixed combination product or as separate component. BP , Benzoyl peroxide. Hide Pane Expand all Collapse all Article Outline Acne is one of the most common disorders treated by dermatologists and other health care providers. While it most often affects adolescents, it is not uncommon in adults

2016 American Academy of Dermatology

109. A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne

A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) half of the participants will receive a cleanser, a light therapy topical gel-cream, and a light therapy mask. Condition or disease Intervention/treatment Phase Acne Vulgaris Device: Cleanser, Acne Mask Device: Cleanser, Gel-Cream, Acne Mask Not Applicable Detailed Description: Acne vulgaris is a common chronic skin disease involving blockage and/or inflammation of the hair follicles and their accompany sebaceous glands. Research has shown the benefits of red and blue light therapy in the treatment

2017 Clinical Trials

110. Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females. Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) TM Collaborator: Skin Laser & Surgery Specialists Information provided by (Responsible Party): Next Science TM Study Details Study Description Go to Brief Summary: To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind manner. Condition or disease

2017 Clinical Trials

111. Management of acne: Canadian clinical practice guideline (Full text)

Management of acne: Canadian clinical practice guideline 26573753 2016 06 03 2018 11 13 1488-2329 188 2 2016 Feb 02 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Management of acne: Canadian clinical practice guideline. 118-26 10.1503/cmaj.140665 Asai Yuka Y Department of Medicine (Asai), Queen's University, Kingston, Ont.; private practice (Baibergenova), Markham, Ont.; Dermatology (Dutil), Women's College Hospital, University of Toronto (...) . eng Journal Article Practice Guideline Research Support, Non-U.S. Gov't Video-Audio Media 2015 11 16 Canada CMAJ 9711805 0820-3946 AIM IM Acne Vulgaris diagnosis therapy Canada Combined Modality Therapy Humans Severity of Illness Index 2015 11 18 6 0 2015 11 18 6 0 2016 6 4 6 0 ppublish 26573753 cmaj.140665 10.1503/cmaj.140665 PMC4732962 J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):746-54 9366821 J Am Acad Dermatol. 1998 Aug;39(2 Pt 3):S34-7 9703121 Br J Dermatol. 1998 Nov;139(5):846-50 9892952 Br J

2016 CMAJ : Canadian Medical Association Journal PubMed

112. Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris. (PubMed)

Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris. The multiple etiologic factors involved in acne make the use of various medications necessary to treat the condition. This study aimed to determine the efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris. In a multicentre, randomized controlled, triple-blinded study, a total of 105 acne patients, with a clinical diagnosis of moderate to severe acne (...) with standard treatment in the management of acne vulgaris, although none of the treatments had superior efficacy compared with the others.

2013 Iranian journal of pharmaceutical research : IJPR

113. Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02566369 Recruitment Status : Completed First Posted : October 2, 2015 Last Update Posted : July 10, 2018 Sponsor: Galderma

2015 Clinical Trials

114. A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02595034 Recruitment Status : Completed First Posted : November 3, 2015 Last Update Posted : May 4, 2017 Sponsor: Taro

2015 Clinical Trials

115. A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved (...) Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our

2015 Clinical Trials

116. A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onextonâ„¢ Gel in the Treatment of Acne Vulgaris

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onextonâ„¢ Gel in the Treatment of Acne Vulgaris A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02578043 Recruitment Status : Completed First Posted : October

2015 Clinical Trials

117. A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204

A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Thorough ECG (...) Study in Subjects With Acne Vulgaris Treated With SB204 The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02581072 Recruitment Status : Completed First Posted : October 20, 2015 Last Update Posted : November 19, 2018 Sponsor: Novan, Inc. Collaborator: Spaulding Clinical Research LLC Information

2015 Clinical Trials

118. A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02608476 Recruitment Status : Completed First Posted : November 18, 2015 Last

2015 Clinical Trials

119. A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02608450 Recruitment Status : Completed First Posted : November 18, 2015 Last

2015 Clinical Trials

120. Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris

Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Benzac 5% Gel (...) in Combination With Cosmetic Products in Acne Vulgaris (Benzac) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02589405 Recruitment Status : Completed First Posted : October 28, 2015 Results First Posted : February 11, 2019 Last Update Posted : February 11, 2019 Sponsor: Galderma Collaborator: Proinnovera

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>